Low-dose clozapine improves dyskinesias in Parkinson's disease.
about
The role of alpha2-adrenoceptor antagonism in the anti-cataleptic properties of the atypical neuroleptic agent, clozapine, in the ratWorsening of levodopa-induced dyskinesias by motor and mental tasksEffects of serotonin 5-HT1A agonist in advanced Parkinson's disease.Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia.Other pharmacological treatments for motor complications and dyskinesias.Enhancing aromatic L-amino acid decarboxylase activity: implications for L-DOPA treatment in Parkinson's disease.How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?Levodopa delivery systems: advancements in delivery of the gold standard.Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease.Advances in non-dopaminergic treatments for Parkinson's diseaseMechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.Schizophrenia with Comorbid Idiopathic Parkinson's Disease: A Difficult Clinical Management Scenario.Management of punding in Parkinson's disease: an open-label prospective study.
P2860
Q28368762-26B492C4-5A04-4858-B8E6-C8EDFEB59941Q28372142-AB68A0D3-3A70-4B2F-BCE7-29A19CC0A17FQ34406533-014E2A84-8B78-46E4-8D7F-1610E632D22AQ35324977-2EF66045-7184-49B0-A799-2A3CBCA94845Q36094528-58758B9E-AEE3-418D-B1C2-B4B68F613ABDQ37336895-8E1A1650-533C-46DA-9775-88A91A05FD09Q37363909-3E2FA967-D50E-4058-801B-BBE30437ED1BQ37679951-A052134D-1BC6-42F5-93ED-58BDD95BA79FQ37924629-57C8B22A-DBD3-4C1A-AD82-65D1FFA153ECQ37973611-95B07694-C701-4F52-BF23-E86514FA1440Q38218083-F85A51F9-F8BA-49A6-BC47-585B8774F147Q41846717-C84CB4BB-39FA-41D3-B8A7-3AACAC3BC362Q43693354-457B017D-8887-4210-B9C1-411753CE0AD1Q47100111-56871CB8-0E98-4E39-8912-BF7CE7830CE6Q51638270-EA3488DD-CDB8-4805-9A73-4EB41833E0B4
P2860
Low-dose clozapine improves dyskinesias in Parkinson's disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Low-dose clozapine improves dyskinesias in Parkinson's disease.
@en
Low-dose clozapine improves dyskinesias in Parkinson's disease.
@nl
type
label
Low-dose clozapine improves dyskinesias in Parkinson's disease.
@en
Low-dose clozapine improves dyskinesias in Parkinson's disease.
@nl
prefLabel
Low-dose clozapine improves dyskinesias in Parkinson's disease.
@en
Low-dose clozapine improves dyskinesias in Parkinson's disease.
@nl
P50
P356
P1433
P1476
Low-dose clozapine improves dyskinesias in Parkinson's disease.
@en
P304
P356
10.1212/WNL.48.3.658
P4011
c650af9a775093324819a2e73c54e805b1f0b99a
P407
P577
1997-03-01T00:00:00Z